KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Revenue (2018 - 2025)

Historic Revenue for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $313.3 million.

  • Progyny's Revenue rose 932.26% to $313.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1141.26%. This contributed to the annual value of $1.2 billion for FY2024, which is 722.24% up from last year.
  • According to the latest figures from Q3 2025, Progyny's Revenue is $313.3 million, which was up 932.26% from $332.9 million recorded in Q2 2025.
  • In the past 5 years, Progyny's Revenue registered a high of $332.9 million during Q2 2025, and its lowest value of $122.1 million during Q1 2021.
  • Over the past 5 years, Progyny's median Revenue value was $269.9 million (recorded in 2023), while the average stood at $237.6 million.
  • Its Revenue has fluctuated over the past 5 years, first surged by 9913.47% in 2021, then skyrocketed by 204.14% in 2024.
  • Over the past 5 years, Progyny's Revenue (Quarter) stood at $127.6 million in 2021, then skyrocketed by 68.03% to $214.3 million in 2022, then increased by 25.95% to $269.9 million in 2023, then grew by 10.55% to $298.4 million in 2024, then grew by 5.0% to $313.3 million in 2025.
  • Its Revenue stands at $313.3 million for Q3 2025, versus $332.9 million for Q2 2025 and $324.0 million for Q1 2025.